Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study).
Gentile I, Giaccone A, Scirocco MM, Di Brizzi F, Cuccurullo F, Silvitelli M, Ametrano L, Alfè FA, Pietroluongo D, Irace I, Chiariello M, De Felice N, Severino S, Viceconte G, Schiano Moriello N, Maraolo AE, Buonomo AR, Scotto R; Federico II COVID team.
Gentile I, et al.
BMC Infect Dis. 2024 Dec 18;24(1):1434. doi: 10.1186/s12879-024-10303-5.
BMC Infect Dis. 2024.
PMID: 39696011
Free PMC article.